Putri, Devi Andiani, Didik Setiawan, and Muhammad Yamsun. “Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-Mutation Colorectal Cancer”. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) 22, no. 1 (August 19, 2025): 6–11. Accessed June 6, 2026. http://jurnalnasional.ump.ac.id/index.php/PHARMACY/article/view/24298.